IASLC promotes webinar on stereotactic radiation therapy in lung cancer
On April 22, the International Association for the Study of Lung Cancer (IASLC) promotes a webinar dedicated to the topic of Stereotactic Body Radiotherapy (SBRT), presented by Dr. Shahed Badiyan (Washington University School of Medicine) and Dr. David Palma (Ontario Institute for Cancer Research), and moderated by Dr. Corinne Faivre-Finn (University of Manchester).
SBRT is currently a standard treatment for early-stage non-small cell lung cancer in patients for whom surgery is not an option, with high cure rates and acceptable toxicity. The indications for SBRT in lung cancer also extend to the treatment of oligometastatic disease and oligoprogression, among others. This technique consists of the use of ablative radiation doses in hypofractionation schemes, using precise immobilization techniques, highly shaped planning and image-guided treatments.
In this 1-hour webinar, four scenarios will be discussed that are particularly challenging in the application of SBRT in lung cancer:
– Interstitial lung disease
– Ultracentral tumors
– Oligometastatic lung cancer
Presenting representative cases, the therapeutic approach in these challenging situations will be discussed, as well as the published data that support each decision.
The event takes place at 16h in mainland Portugal time (GMT + 1).
You can sign up for free at: